Stem Cell Therapies Benefit Alport Syndrome
Open Access
- 1 November 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 20 (11), 2359-2370
- https://doi.org/10.1681/asn.2009010123
Abstract
Patients with Alport syndrome progressively lose renal function as a result of defective type IV collagen in their glomerular basement membrane. In mice lacking the α3 chain of type IV collagen (Col4A3 knockout mice), a model for Alport syndrome, transplantation of wild-type bone marrow repairs the renal disease. It is unknown whether cell-based therapies that do not require transplantation have similar potential. Here, infusion of wild-type bone marrow-derived cells into unconditioned, nonirradiated Col4A3 knockout mice during the late stage of disease significantly improved renal histology and function. Furthermore, transfusion of unfractionated wild-type blood into unconditioned, nonirradiated Col4A3 knockout mice improved the renal phenotype and significantly improved survival. Injection of mouse and human embryonic stem cells into Col4A3 knockout mice produced similar results. Regardless of treatment modality, the improvement in the architecture of the glomerular basement membrane is associated with de novo expression of the α3(IV) chain. These data provide further support for testing cell-based therapies for Alport syndrome.Keywords
This publication has 18 references indexed in Scilit:
- Irradiation Prolongs Survival of Alport MiceJournal of the American Society of Nephrology, 2008
- Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal diseaseLaboratory Investigation, 2008
- Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritisKidney International, 2007
- Bone Marrow‐Derived Cells Contribute to Podocyte Regeneration and Amelioration of Renal Disease in a Mouse Model of Alport SyndromeThe International Journal of Cell Cloning, 2006
- Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient miceKidney International, 2006
- Loss of α3/α4(IV) Collagen from the Glomerular Basement Membrane Induces a Strain-Dependent Isoform Switch to α5α6(IV) Collagen Associated with Longer Renal Survival in Col4a3 −/− Alport MiceJournal of the American Society of Nephrology, 2006
- Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney diseaseProceedings of the National Academy of Sciences of the United States of America, 2006
- Basement membranes: structure, assembly and role in tumour angiogenesisNature Reviews Cancer, 2003
- Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome.Genes & Development, 1996
- Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome.The Journal of cell biology, 1996